Tulip Chakraborty
WRITTEN BY Tulip Chakraborty
Novartis’s Iptacopan Shows Promising Results as First in Class Oral Therapy for Rare Renal Disease
2020-10-28
Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
2020-10-24
COVID-19: Roche Collaborates with Boston-Based Biopharma To Develop First Novel Oral Antiviral
2020-10-23